Clinical Trial: Reduced Vaccine Response to HZ/su in SLE

U.S., June 10 -- ClinicalTrials.gov registry received information related to the study (NCT07636044) titled 'Reduced Vaccine Response to HZ/su in SLE' on Sept. 27, 2024.

Brief Summary: The goal of this observational study is to compare the vaccine response to the 2 doses of the adjuvanted herpes zoster subunit vaccine(HZ/su, "Shingrix") in patients with SLE and the age-, sex-, ethnicity-matched controls without autoimmune disease.

Study Start Date: Oct. 01, 2024

Study Type: OBSERVATIONAL

Condition: Vaccine Reaction Zoster Systemic Lupus Erythematosus

Recruitment Status: RECRUITING

Sponsor: Seoul National University Hospital

Information provided by (Responsible Party): Eun Bong Lee, Seoul National University Hospital

Published by HT...